The present invention relates to a single-use medical device and more particularly to a two-piece ophthalmic injection device with a disposable tip end containing a temperature control device and temperature sensor assembly.
Several diseases and conditions of the posterior segment of the eye threaten vision. Age related macular degeneration (ARMD), choroidal neovascularization (CNV), retinopathies (e.g., diabetic retinopathy, vitreoretinopathy), retinitis (e.g., cytomegalovirus (CMV) retinitis), uveitis, macular edema, glaucoma, and neuropathies are several examples.
These, and other diseases, can be treated by injecting a drug into the eye. Such injections are typically manually performed using a conventional syringe and needle.
In using such a syringe, the surgeon is required to pierce the eye tissue with the needle, hold the syringe steady, and actuate the syringe plunger (with or without the help of a nurse) to inject the fluid into the eye. The volume injected is typically not controlled in an accurate manner because reading the vernier is subject to parallax error. Fluid flow rates are uncontrolled. and tissue damage may occur due to an “unsteady” injection. Reflux of the drug may also occur when the needle is removed from the eye.
An effort has been made to control the delivery of small amounts of liquids. A commercially available fluid dispenser is the ULTRA™ positive displacement dispenser available from EFD Inc. of Providence, R.I. The ULTRA dispenser is typically used in the dispensing of small volumes of industrial adhesives. It utilizes a conventional syringe and a custom dispensing tip. The syringe plunger is actuated using an electrical stepper motor and an actuating fluid. With this type of dispenser, the volumes delivered are highly dependent on fluid viscosity, surface tension, and the specific dispensing tip. Parker Hannifin Corporation of Cleveland, Ohio distributes a small volume liquid dispenser for drug discovery applications made by Aurora Instruments LLC of San Diego, Calif. The Parker/Aurora dispenser utilizes a piezo-electric dispensing mechanism. While precise, this dispenser is expensive and requires an electrical signal to be delivered to the dispensing mechanism.
U.S. Pat. No. 6,290,690 discloses an ophthalmic system for injecting a viscous fluid (e.g. silicone oil) into the eye while simultaneously aspirating a second viscous fluid (e.g. perfluorocarbon liquid) from the eye in a fluid/fluid exchange during surgery to repair a retinal detachment or tear. The system includes a conventional syringe with a plunger. One end of the syringe is fluidly coupled to a source of pneumatic pressure that provides a constant pneumatic pressure to actuate the plunger. The other end of the syringe is fluidly coupled to an infusion cannula via tubing to deliver the viscous fluid to be injected.
It would be desirable to have a portable hand piece for injecting a drug into the eye. Such a hand piece can include a limited reuse assembly attachable to and removable from a disposable tip segment. The disposable tip segment contains the drug, a needle for administering the drug, and a temperature control device, such as a heater, for altering the temperature of the drug. In order to facilitate assembly of the device, it would be desirable to have a temperature control device integrated with a thermal sensor in a single assembly.
In one embodiment consistent with the principles of the present invention, the present invention is a dispensing assembly with a dispensing chamber housing, a temperature control device, and a thermal sensor. The dispensing chamber housing has an inner surface, an outer surface, and a wall thickness. The inner surface partially defines a dispensing chamber for receiving a quantity of a substance. The temperature control device at least partially surrounds the dispensing chamber housing. The temperature control device alters a temperature of a substance in the dispensing chamber. The temperature control device and the thermal sensor are located on the substrate.
In another embodiment consistent with the principles of the present invention, the present invention is a single piece temperature control assembly. The assembly includes a temperature control device and a thermal sensor located on a substrate. The thermal sensor is arranged on the substrate such that the distance between the thermal sensor and the temperature control device is approximately equal to the distance between the temperature control device and a substance whose temperature is to be altered by the temperature control device.
In another embodiment consistent with the principles of the present invention, the present invention is a dispensing assembly having a dispensing chamber housing, a temperature control device, a thermal sensor, and an interface. The dispensing chamber housing has an inner surface, an outer surface, and a wall thickness. The inner surface partially defines a dispensing chamber for receiving a quantity of a substance. The temperature control device at least partially surrounds the dispensing chamber housing. The temperature control device alters a temperature of a substance in the dispensing chamber. The temperature control device and the thermal sensor are located on a substrate. The interface is connected to the temperature control device and the thermal sensor. An interface connector is connected to the interface. The distance between the temperature control device and the thermal sensor is approximately equal to the wall thickness of the dispensing chamber housing. The substrate is wrapped around an exterior surface of the dispensing chamber housing.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are intended to provide further explanation of the invention as claimed. The following description, as well as the practice of the invention, set forth and suggest additional advantages and purposes of the invention.
The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several embodiments of the invention and together with the description, serve to explain the principles of the invention.
Reference is now made in detail to the exemplary embodiments of the invention, examples of which are illustrated in the accompanying figures. Wherever possible, the same reference numbers are used throughout the figures to refer to the same or like parts.
Tip segment 205 is capable of being connected to and removed from limited reuse assembly 250. In this embodiment, tip segment 205 has a threaded portion on an interior surface of housing 215 that screws onto the threaded portion 260 of limited reuse assembly 250. In addition, lock mechanism 265 secures tip segment 215 to limited reuse assembly 250. Lock mechanism 265 may be in the form of a button, a sliding switch, or a cantilevered mechanism. Other mechanisms for connecting tip segment 205 to limited reuse assembly 250, such as those involving structural features that mate with each other, are commonly known in the art and are within the scope of the present invention.
Needle 210 is adapted to deliver a substance, such as a drug, into an eye. Needle 210 may be of any commonly known configuration. Preferably, needle 210 is designed such that its thermal characteristics are conducive to the particular drug delivery application. For example, when a heated drug is to be delivered, needle 210 may be relatively short (several millimeters) in length to facilitate proper delivery of the drug based on thermal characteristics.
Switch 270 is adapted to provide an input to the system. For example, switch 270 may be used to activate the system or to turn on a heater. Other switches, buttons, or user-directed control inputs are commonly known and may be employed with limited reuse assembly 250 and/or tip segment 205.
Optional light 275 is illuminated when tip segment 205 is ready to be used. Optional light 275 may protrude from housing 215, or it may be contained within housing 215, in which case, optional light 275 may be seen through a clear portion of housing 215. In other embodiments, optional light 275 may be replaced by an indicator, such as a liquid crystal display, segmented display, or other device that indicates a status or condition of disposable tip segment 205. For example, optional light 275 may also pulse on and off to indicate other states, such as, but not limited to a system error, fully charged battery, insufficiently charged battery or faulty connection between the tip segment 205 and limited use assembly 250. While shown on tip segment 205, optional light 275 or another indicator may be located on limited reuse assembly 250.
In tip segment 205, plunger interface 420 is located on one end of plunger 415. The other end of plunger 415 forms one end of dispensing chamber 405. Plunger 415 is adapted to slide within dispensing chamber 405. An outer surface of plunger 415 is fluidly sealed to the inner surface of dispensing chamber housing 425. Dispensing chamber housing 425 surrounds the dispensing chamber 405. Typically, dispensing chamber housing 425 has a cylindrical shape. As such, dispensing chamber 405 also has a cylindrical shape.
Needle 210 is fluidly coupled to dispensing chamber 405. In such a case, a substance contained in dispensing chamber 405 can pass through needle 210 and into an eye. Temperature control device 450 at least partially surrounds dispensing chamber housing 425. In this case, temperature control device 450 is adapted to heat and/or cool dispensing chamber housing 425 and any substance contained in dispensing chamber 405. The arrangement of temperature control device 450 and dispensing thermal sensor 460 is described in more detail below. Interface 530 connects temperature control device 450 and thermal sensor 460 with tip interface connector 520.
The components of tip segment 205, including dispensing chamber housing 425, temperature control device 450, and plunger 415 are at least partially enclosed by tip segment housing 215. In one embodiment consistent with the principles of the present invention, plunger 415 is sealed to the interior surface of dispensing chamber housing 425. This seal prevents contamination of any substance contained in dispensing chamber 405. For medical purposes, such a seal is desirable. This seal can be located at any point on plunger 415 or dispensing chamber housing 425.
In limited reuse assembly 250, power source 505 provides power to actuator 515. An interface (not shown) between power source 505 and actuator 515 serves as a conduit for providing power to actuator 515. Actuator 515 is connected to actuator shaft 510. When actuator 515 is a stepper motor, actuator shaft 510 is integral with actuator 515. Mechanical linkage interface 545 is connected to actuator shaft 510. In this configuration, as actuator 515 moves actuator shaft 510 upward toward needle 210 mechanical linkage interface 545 also moves upward toward needle 210.
Controller 305 is connected via interface 535 to limited reuse assembly interface connector 525. Limited reuse assembly interface connector 525 is located on a top surface of limited reuse assembly housing 255 adjacent to mechanical linkage interface 545. In this manner, both limited reuse assembly interface connector 525 and mechanical linkage interface 545 are adapted to be connected with tip interface connector 520 and plunger interface 420 respectively.
Controller 305 and actuator 515 are connected by an interface (not shown). This interface (not shown) allows controller 305 to control the operation of actuator 515. In addition, an interface (not shown) between power source 505 and controller 305 allows controller 305 to control operation of power source of 310. In such a case, controller 305 may control the charging and the discharging of power source 505 when power source 505 is a rechargeable battery.
Controller 305 is typically an integrated circuit with power, input, and output pins capable of performing logic functions. In various embodiments, controller 305 is a targeted device controller. In such a case, controller 305 performs specific control functions targeted to a specific device or component, such as a temperature control device or a power supply. For example, a temperature control device controller has the basic functionality to control a temperature control device. In other embodiments, controller 305 is a microprocessor. In such a case, controller 305 is programmable so that it can function to control more than one component of the device. In other cases, controller 305 is not a programmable microprocessor, but instead is a special purpose controller configured to control different components that perform different functions. While depicted as one component, controller 305 may be made of many different components or integrated circuits.
Tip segment 205 is adapted to mate with or attach to limited reuse assembly 250 as previously described. In the embodiment of
In operation, when tip segment 205 is connected to limited reuse assembly 250, controller 305 controls the operation of actuator 515. Actuator 515 is actuated and actuator shaft 510 is moved upward toward needle 210. In turn, mechanical linkage interface 545, which is mated with plunger interface 420, moves plunger 415 upward toward needle 210. A substance located in dispensing chamber 405 is then expelled through needle 210.
In addition, controller 305 controls the operation of temperature control device 450. Temperature control device 450 is adapted to heat and/or cool dispensing chamber housing 425. Since dispensing chamber housing 425 is at least partially thermally conductive, heating or cooling dispensing chamber housing 425 heats or cools a substance located in dispensing chamber 405. Temperature information can be transferred from thermal sensor 460 to controller 305 via any of a number of different interface configurations. This temperature information can be used to control the operation of temperature control device 450. When temperature control device 450 is a heater, controller 305 controls the amount of current that is sent to temperature control device 450. The more current sent to temperature control device 450, the hotter it gets. In such a manner, controller 305 can use a feed back loop utilizing information from thermal sensor 460 to control the operation of temperature control device 450. Any suitable type of control algorithm, such as a proportional integral derivative (PID) algorithm, can be used to control the operation of temperature control device 450.
In the embodiment of
In various embodiments of the present invention, temperature control device 450 is a heating and/or a cooling device. Temperature control device 450 is in thermal contact with dispensing chamber housing 425. As such, temperature control device 450 is capable of changing the temperature of the substance in dispensing chamber 405. Interface 530 and tip interface connector 520 couple temperature control device 450 to a limited reuse assembly. In such a case, temperature control device 450 can be powered and controlled by the limited reuse assembly. In one embodiment of the present invention, temperature control device 450 receives current via interface 530 from a limited reuse assembly. Providing current in one direction (i.e., a positive voltage across the device) causes temperature control device 450 to heat. Providing current in the opposite direction (i.e., a negative voltage across the device) causes temperature control device 450 to cool.
A substance to be delivered into an eye, typically a drug, is located in dispensing chamber 405. In this manner, the substance is contacted by the inner surface of dispensing chamber housing 425 and one face of plunger 415. Typically, dispensing chamber 405 is cylindrical in shape. Temperature control device 450 is in thermal contact with dispensing chamber housing 425. In this manner, temperature control device 450 is adapted to control the temperature of the contents of dispensing chamber 425. Thermal sensor 460 provides temperature information to assist in controlling the operation of temperature control device 450.
In one embodiment of the present invention, the substance located in dispensing chamber 405 is a drug that is preloaded into the dispensing chamber. In such a case, disposable tip segment 205 is appropriate as a single use consumable product. Such a disposable product can be assembled at a factory with a dosage of a drug installed.
When a drug is preloaded into dispensing chamber 405, a set quantity of the drug can be preloaded. For example, 100 microliters of a drug can be loaded into dispensing chamber 405, and any quantity up to 100 microliters can be dispensed. In such a case, the plunger 415 can be moved a precise distance to deliver a precise dosage of drug from the dispensing chamber 405, through the needle 210, and into an eye. This provides for flexibility of dosing and for ease of assembly.
From the above, it may be appreciated that the present invention provides an improved system for delivering precise volumes of a substance into an eye. The present invention provides a single use, disposable delivery device tip segment that is capable of delivering a dosage of a drug. The tip segment interfaces with a limited reuse assembly. The disposable tip segment has an assembly that includes a temperature control device and a thermal sensor. The construction of the assembly allows for easy manufacture and assembly of the device while allowing for reliable injection procedures.
While the present invention is described in the context of a single-use ophthalmic drug delivery device, the present invention encompasses any medical device or injection device. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
This Application is a continuation-in-part of U.S. patent application Ser. No. 11/581,629 filed Oct. 16, 2006, U.S. patent application Ser. No. 11/581,630 filed Oct. 16, 2006, U.S. patent application Ser. No. 11/581,591 filed Oct. 16, 2006, and is related to U.S. patent application Ser. No. 11/435,906 filed May 17, 2006.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2007/080078 | 10/1/2007 | WO | 00 | 4/2/2009 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2008/108886 | 9/12/2008 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1252614 | Pieper | Jan 1918 | A |
2491266 | Hooper | Dec 1949 | A |
2710909 | Logan et al. | Jun 1955 | A |
3089815 | Lieb et al. | May 1963 | A |
3199740 | Huffa et al. | Aug 1965 | A |
3608549 | Merrill | Sep 1971 | A |
3858581 | Kamen | Jan 1975 | A |
3892537 | Gulati et al. | Jul 1975 | A |
3982537 | Bucalo | Sep 1976 | A |
4007742 | Banko | Feb 1977 | A |
4030499 | Bucalo | Jun 1977 | A |
4054138 | Bucalo | Oct 1977 | A |
4122850 | Bucalo | Oct 1978 | A |
4184510 | Murry et al. | Jan 1980 | A |
4246932 | Raines | Jan 1981 | A |
4265618 | Herskovitz et al. | May 1981 | A |
4357136 | Herskovitz et al. | Nov 1982 | A |
4392827 | Martin | Jul 1983 | A |
4474752 | Haslam et al. | Oct 1984 | A |
4484915 | Tartaglia | Nov 1984 | A |
4582488 | Newman | Apr 1986 | A |
4684344 | Brockway et al. | Aug 1987 | A |
4704088 | Newman | Nov 1987 | A |
4713446 | DeVore et al. | Dec 1987 | A |
4764165 | Reimels et al. | Aug 1988 | A |
4795423 | Osterholm | Jan 1989 | A |
4810859 | Anabtawi et al. | Mar 1989 | A |
4830855 | Stewart | May 1989 | A |
4911161 | Schechter | Mar 1990 | A |
4992045 | Beisel | Feb 1991 | A |
5066276 | Wang | Nov 1991 | A |
5120307 | Wang | Jun 1992 | A |
5271085 | Carballo | Dec 1993 | A |
5328481 | Wang | Jul 1994 | A |
5336175 | Mames | Aug 1994 | A |
5360413 | Leason et al. | Nov 1994 | A |
5370630 | Smidebush et al. | Dec 1994 | A |
5431630 | Leonard | Jul 1995 | A |
5476511 | Gwon et al. | Dec 1995 | A |
5487725 | Peyman | Jan 1996 | A |
5503144 | Bacon | Apr 1996 | A |
5582595 | Haber et al. | Dec 1996 | A |
5602188 | Nakanishi | Feb 1997 | A |
5620700 | Berggren et al. | Apr 1997 | A |
5662612 | Niehoff | Sep 1997 | A |
5743886 | Lynn et al. | Apr 1998 | A |
5773019 | Ashton et al. | Jun 1998 | A |
5783205 | Berggren et al. | Jul 1998 | A |
5824072 | Wong | Oct 1998 | A |
5860949 | Chen | Jan 1999 | A |
5882338 | Gray | Mar 1999 | A |
5928197 | Niehoff | Jul 1999 | A |
5928663 | Peyman | Jul 1999 | A |
5984889 | Christ et al. | Nov 1999 | A |
5989238 | Ginsburg | Nov 1999 | A |
6051011 | Weidenbenner | Apr 2000 | A |
6165190 | Nguyen | Dec 2000 | A |
6210357 | Morris | Apr 2001 | B1 |
6221045 | Duchon et al. | Apr 2001 | B1 |
6259074 | Brunner et al. | Jul 2001 | B1 |
6270343 | Martin | Aug 2001 | B1 |
6290690 | Huculak et al. | Sep 2001 | B1 |
6311868 | Krietemeier et al. | Nov 2001 | B1 |
6364865 | Lavi et al. | Apr 2002 | B1 |
6372245 | Bowman et al. | Apr 2002 | B1 |
6372246 | Bowman et al. | Apr 2002 | B1 |
6413245 | Yaacobi et al. | Jul 2002 | B1 |
6419656 | Vetter et al. | Jul 2002 | B1 |
6436143 | Ross et al. | Aug 2002 | B1 |
6488659 | Rosenman | Dec 2002 | B1 |
6520930 | Critchlow et al. | Feb 2003 | B2 |
6585700 | Trocki et al. | Jul 2003 | B1 |
6595979 | Epstein et al. | Jul 2003 | B1 |
6620189 | Machoold et al. | Sep 2003 | B1 |
6635267 | Miyoshi et al. | Oct 2003 | B1 |
6645179 | Ishikawa et al. | Nov 2003 | B1 |
6726654 | Rosenman | Apr 2004 | B2 |
6940209 | Henderson | Sep 2005 | B2 |
6991457 | Kazen et al. | Jan 2006 | B2 |
7176030 | Faries, Jr. et al. | Feb 2007 | B2 |
20020055720 | Hohlfelder et al. | May 2002 | A1 |
20030055380 | Flaherty | Mar 2003 | A1 |
20030125665 | Rosenman | Jul 2003 | A1 |
20040039253 | Peyman et al. | Feb 2004 | A1 |
20040052761 | Vernon et al. | Mar 2004 | A1 |
20040054319 | Langley et al. | Mar 2004 | A1 |
20040133155 | Varner et al. | Jul 2004 | A1 |
20040167466 | Drasler et al. | Aug 2004 | A1 |
20040176720 | Kipfer | Sep 2004 | A1 |
20040204673 | Faherty | Oct 2004 | A1 |
20040210200 | Gerondale et al. | Oct 2004 | A1 |
20040231667 | Horton et al. | Nov 2004 | A1 |
20050065477 | Jost | Mar 2005 | A1 |
20060047250 | Hickingbotham | Mar 2006 | A1 |
20070016186 | LoRusso | Jan 2007 | A1 |
20070060887 | Marsh et al. | Mar 2007 | A1 |
20070142769 | Griffiths et al. | Jun 2007 | A1 |
20070270750 | Dacquay et al. | Nov 2007 | A1 |
20090069806 | De La Mora Levy et al. | Mar 2009 | A1 |
Number | Date | Country |
---|---|---|
7623298 | Jun 1998 | AU |
1313802 | Feb 1993 | CA |
3434930 | Apr 1986 | DE |
0 516 292 | Feb 1922 | EP |
0348146 | Jun 1989 | EP |
0356372 | Feb 1990 | EP |
0398394 | Nov 1990 | EP |
0520443 | Dec 1992 | EP |
1516638 | Mar 2005 | EP |
1704840 | Sep 2006 | EP |
1551767 | May 1979 | GB |
2002059055 | Feb 2002 | JP |
2270032 | Feb 2006 | RU |
285170 | Oct 1970 | SU |
WO 8203761 | Nov 1982 | WO |
WO 8700029 | Jan 1987 | WO |
WO 9311818 | Jun 1993 | WO |
WO 9603978 | Feb 1996 | WO |
WO 9933853 | Jul 1999 | WO |
WO 0074752 | Dec 2000 | WO |
WO 0110482 | Feb 2001 | WO |
WO 0207658 | Jan 2002 | WO |
WO 03006098 | Jan 2003 | WO |
WO 2005027578 | Mar 2005 | WO |
WO 2006037969 | Apr 2006 | WO |
WO 2006050008 | May 2006 | WO |
WO 2006067480 | Jun 2006 | WO |
WO 2006108026 | Oct 2006 | WO |
Entry |
---|
Ultra™ 2800 Positive Displacement; 2004; EFD, Inc. Brochure XP 1104 vol. 11.10; 2 pages. |
Parker: Your Resource for Motion and Fluid Control Components, Systems and Solutions—Systems Solutions for Life Sciences; 2003; Aurora Instruments, LLC Brochure; 8 pages. |
Number | Date | Country | |
---|---|---|---|
20100106089 A1 | Apr 2010 | US |
Number | Date | Country | |
---|---|---|---|
60921497 | Oct 2006 | US | |
60921499 | Oct 2006 | US | |
60921498 | Oct 2006 | US |